Incidence and clinical implications of late immune-related adverse events in long responders to PD-1/PD-L1 checkpoint inhibitors: A multicenter study

被引：0

作者：

Nigro, O. ^{[1
]}

Cortellini, A. ^{[2
]}

Giusti, R. ^{[3
]}

Marchetti, P. ^{[3
]}

De Galitiis, F. ^{[4
]}

Di Pietro, F. R. ^{[4
]}

Bersanelli, M. ^{[5
]}

Lazzarin, A. ^{[5
]}

Galetta, D. ^{[6
]}

Pizzutillo, P. ^{[6
]}

Santini, D. ^{[7
]}

Torniai, M. ^{[8
]}

De Giglio, A. ^{[9
]}

Russo, A. ^{[10
,11
]}

Silva, R. R. ^{[12
]}

Bolzacchini, E. ^{[13
]}

Natoli, C. ^{[14
]}

Rijavec, E. ^{[15
]}

Vallini, I. ^{[1
]}

Pinotti, G. ^{[1
]}

机构：

[1] Osped Circolo Varese, ASST Sette Laghi, Med Oncol, Varese, Italy

[2] St Salvatore Hosp, Med Oncol, Laquila, Italy

[3] Azienda Osped Univ St Andrea, Med Oncol, Rome, Italy

[4] IRCCS, IDI, Oncol & Oncol Dermatol, Rome, Italy

[5] Azienda Osped Univ Parma, Med Oncol, Parma, Italy

[6] Clin Canc Ctr Giovanni Paolo II, Thorac Oncol Unit, Bari, Italy

[7] Campus Biomed, Med Oncol, Rome, Italy

[8] Univ Politecn Marche, Azienda Osped Univ Ospedali Riuniti Umberto I, Med Oncol, Ancona, Italy

[9] Osped S Maria Misericordia, Oncol Med, Perugia, Italy

[10] AO Papardo, Med Oncol, Messina, Italy

[11] Dept Human Pathol, Messina, Italy

[12] Area Vasta 2, ASUR Marche, Med Oncol, Fabriano, Italy

[13] Osped St Anna, ASST Lariana, Med Oncol, Como, Italy

[14] SS Annunziata Hosp, Med Oncol, Chieti, Italy

[15] Policlin Milano, Med Oncol, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

55P

引用

页数：1

共 50 条

[1] Incidence and clinical implications of late immune-related adverse events in long responders to PD-1/PD-L1 checkpoint inhibitors: a multicenter study
Nigro, Olga
Pinotti, Graziella
Giusti, Raffaele
Filetti, Marco
De Galitiis, Federica
Di Pietro, Francesca Romana
Bersanelli, Melissa
Lazzarin, Alessandro
Catino, Annamaria
Pizzutillo, Pamela
Russano, Marco
Torniai, Mariangela
Ricciuti, Biagio
Russo, Alessandro
Tudini, Marianna
Bolzacchini, Elena
Di Marino, Pietro
Rijavec, Erika
Vallini, Ilaria
Ficorella, Corrado
Cortellini, Alessio
JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
[2] Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study
Nigro, Olga
Pinotti, Graziella
De Galitiis, Federica
Di Pietro, Francesca Romana
Giusti, Raffaele
Filetti, Marco
Bersanelli, Melissa
Lazzarin, Alessandro
Bordi, Paola
Catino, Annamaria
Pizzutilo, Pamela
Galetta, Domenico
Marchetti, Paolo
Botticelli, Andrea
Scagnoli, Simone
Russano, Marco
Santini, Daniele
Torniai, Mariangela
Berardi, Rossana
Ricciuti, Biagio
De Giglio, Andrea
Chiari, Rita
Russo, Alessandro
Adamo, Vincenzo
Tudini, Marianna
Silva, Rosa Rita
Bolzacchini, Elena
Giordano, Monica
Di Marino, Pietro
De Tursi, Michele
Rijavec, Erika
Ghidini, Michele
Vallini, Ilaria
Stucci, Luigia Stefania
Tucci, Marco
Pala, Laura
Conforti, Fabio
Queirolo, Paola
Tanda, Enrica
Spagnolo, Francesco
Cecchi, Federica
Bracarda, Sergio
Macrini, Serena
Santoni, Matteo
Battelli, Nicola
Fargnoli, Maria Concetta
Porzio, Giampiero
Tuzi, Alessandro
Suter, Matteo Basilio
Ficorella, Corrado
EUROPEAN JOURNAL OF CANCER, 2020, 134 : 19 - 28
[3] Retrospective analysis of immune-related adverse events of the immune checkpoint inhibitors of PD-1/PD-l1 in the Fujian provincial hospital
Zheng, Jianping
Cui, Tongjian
Gao, Yu
Li, Ting
EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
[4] Immunogenetic variations predict immune-related adverse events for PD-1/PD-L1 inhibitors
Xin, Zhaodan
You, Liting
Na, Feifei
Li, Jin
Chen, Min
Song, Jiajia
Bai, Ling
Chen, Jie
Zhou, Juan
Ying, Binwu
EUROPEAN JOURNAL OF CANCER, 2023, 184 : 124 - 136
[5] PD-1 immune checkpoint inhibitors and serious immune-related adverse events
Baek, Yeon-Hee
Kang, Eun Joo
Hong, Soojung
Park, So-Hee
Kim, Ju Hwan
Wong, Ian C.
Au, Philip C. -M.
Cheung, Ching-Lung
Shin, Ju-Young
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 293 - 293
[6] Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
Zhou, Yanting
Li, Hongyan
FRONTIERS IN NEUROSCIENCE, 2023, 17
[7] Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
Yoon, Jee Hee
Hong, A. Ram
Kim, Hee Kyung
Kang, Ho-Cheol
ENDOCRINOLOGY AND METABOLISM, 2021, 36 (02) : 413 - 423
[8] Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Griewing, Luisa Maria
Schweizer, Claudia
Schubert, Philipp
Rutzner, Sandra
Eckstein, Markus
Frey, Benjamin
Haderlein, Marlen
Weissmann, Thomas
Semrau, Sabine
Gostian, Antoniu-Oreste
Mueller, Sarina K.
Traxdorf, Maximilian
Iro, Heinrich
Zhou, Jian-Guo
Gaipl, Udo S.
Fietkau, Rainer
Hecht, Markus
BMC CANCER, 2021, 21 (01)
[9] Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Luisa Maria Griewing
Claudia Schweizer
Philipp Schubert
Sandra Rutzner
Markus Eckstein
Benjamin Frey
Marlen Haderlein
Thomas Weissmann
Sabine Semrau
Antoniu-Oreste Gostian
Sarina K. Müller
Maximilian Traxdorf
Heinrich Iro
Jian-Guo Zhou
Udo S. Gaipl
Rainer Fietkau
Markus Hecht
BMC Cancer, 21
[10] Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation
Russano, Marco
Cortellini, Alessio
Giusti, Raffaele
Russo, Alessandro
Zoratto, Federica
Rastelli, Francesca
Gelibter, Alain
Chiari, Rita
Nigro, Olga
De Tursi, Michele
Bracarda, Sergio
Gori, Stefania
Grossi, Francesco
Bersanelli, Melissa
Calvetti, Lorenzo
Di Noia, Vincenzo
Scartozzi, Mario
Di Maio, Massimo
Bossi, Paolo
Falcone, Alfredo
Citarella, Fabrizio
Pantano, Francesco
Ficorella, Corrado
Filetti, Marco
Adamo, Vincenzo
Veltri, Enzo
Pergolesi, Federica
Occhipinti, Mario Alberto
Nicolardi, Linda
Tuzi, Alessandro
Di Marino, Pietro
Macrini, Serena
Inno, Alessandro
Ghidini, Michele
Buti, Sebastiano
Aprile, Giuseppe
Lai, Eleonora
Audisio, Marco
Intagliata, Salvatore
Marconcini, Riccardo
Brocco, Davide
Porzio, Giampiero
Piras, Marta
Rijavec, Erika
Simionato, Francesca
Natoli, Clara
Tiseo, Marcello
Vincenzi, Bruno
Tonini, Giuseppe
Santini, Daniele
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (04) : 865 - 874

← 1 2 3 4 5 →